With third bio-train complete, Catalent eyes fourth and fifth in WisconsinAllbiopro2018-09-01T14:30:46+09:009월 1st, 2018|
Alcami and UNCW Awarded $1.12M Biomanufacturing Workforce Development GrantAllbiopro2018-09-01T14:29:41+09:009월 1st, 2018|
Alcami and UNCW Awarded $1.12M Biomanufacturing Workforce Development GrantAllbiopro2018-09-01T14:29:05+09:009월 1st, 2018|
EC Approves GSK’s Nucala for Pediatric Treatment of Severe AsthmaAllbiopro2018-09-01T14:28:35+09:009월 1st, 2018|
Evotec and CHDI Foundation extend ongoing collaboration to fight Huntington’s diseaseAllbiopro2018-09-01T14:27:34+09:009월 1st, 2018|
REGENXBIO Looks to Take CLN2 Gene Therapy Treatment Into the ClinicAllbiopro2018-08-31T10:45:01+09:008월 31st, 2018|
RootPath Receives $7 Million Seed Funding for Next-Gen Immuno-OncologyAllbiopro2018-08-31T10:44:31+09:008월 31st, 2018|
FDA Launches New Pilot Program for Complex Trial DesignAllbiopro2018-08-31T10:44:00+09:008월 31st, 2018|
Vertex and Machine Learning Company Genomics Plc Enter Three Year CollaborationAllbiopro2018-08-31T10:43:29+09:008월 31st, 2018|
During A Busy August, FDA Issues Multiple New Draft Guidance DocumentsAllbiopro2018-08-31T10:42:59+09:008월 31st, 2018|
Biogen, Teva benefit as payers ease up on multiple sclerosis meddling: analystAllbiopro2018-08-31T10:42:28+09:008월 31st, 2018|
Bausch Health quickly revives FDA quest for ‘Significant 7’ hopeful DuobriiAllbiopro2018-08-31T10:41:56+09:008월 31st, 2018|
Amid fierce competition in hemophilia, Bayer scores FDA nod for its long-acting drug JiviAllbiopro2018-08-31T10:41:27+09:008월 31st, 2018|
Pfizer drops muscle-growth antibody after it misses phase 2 endpoint in DMDAllbiopro2018-08-31T10:40:32+09:008월 31st, 2018|
